دورية أكاديمية
أعرض في EDS

Evaluation of the Hematological Patterns from Up to 985 Days of Long COVID: A Cross-Sectional Study.

التفاصيل البيبلوغرافية
العنوان: Evaluation of the Hematological Patterns from Up to 985 Days of Long COVID: A Cross-Sectional Study.
المؤلفون: Galúcio VCA; Center for Biological Health Sciences, State University of Pará (UEPA), Belém 66087-670, Brazil., Menezes DC; Center for Biological Health Sciences, State University of Pará (UEPA), Belém 66087-670, Brazil., Lima PDL; Center for Biological Health Sciences, State University of Pará (UEPA), Belém 66087-670, Brazil., Palácios VRDCM; Center for Biological Health Sciences, State University of Pará (UEPA), Belém 66087-670, Brazil., Vasconcelos PFDC; Center for Biological Health Sciences, State University of Pará (UEPA), Belém 66087-670, Brazil., Quaresma JAS; Center for Biological Health Sciences, State University of Pará (UEPA), Belém 66087-670, Brazil.; School of Medicine, São Paulo University (USP), São Paulo 01246903, Brazil.; Tropical Medicine Center, Federal University of Pará (UFPA), Belém 66055-240, Brazil., Falcão LFM; Center for Biological Health Sciences, State University of Pará (UEPA), Belém 66087-670, Brazil.; School of Medicine, São Paulo University (USP), São Paulo 01246903, Brazil.
المصدر: Viruses [Viruses] 2023 Mar 29; Vol. 15 (4). Date of Electronic Publication: 2023 Mar 29.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Basel, Switzerland : MDPI
مواضيع طبية MeSH: COVID-19*, Humans ; Cross-Sectional Studies ; Erythrocyte Indices ; Hematologic Tests ; Erythrocytes ; Post-Acute COVID-19 Syndrome
مستخلص: Long COVID affects many individuals following acute coronavirus disease 2019 (COVID-19), and hematological changes can persist after the acute COVID-19 phase. This study aimed to evaluate these hematological laboratory markers, linking them to clinical findings and long-term outcomes in patients with long COVID. This cross-sectional study selected participants from a 'long COVID' clinical care program in the Amazon region. Clinical data and baseline demographics were obtained, and blood samples were collected to quantify erythrogram-, leukogram-, and plateletgram-related markers. Long COVID was reported for up to 985 days. Patients hospitalized in the acute phase had higher mean red/white blood cell, platelet, and plateletcrit levels and red blood cell distribution width. Furthermore, hematimetric parameters were higher in shorter periods of long COVID than in longer periods. Patients with more than six concomitant long COVID symptoms had a higher white blood cell count, a shorter prothrombin time (PT), and increased PT activity. Our results indicate there may be a compensatory mechanism for erythrogram-related markers within 985 days of long COVID. Increased levels of leukogram-related markers and coagulation activity were observed in the worst long COVID groups, indicating an exacerbated response after the acute disturbance, which is uncertain and requires further investigation.
References: BMC Infect Dis. 2020 Oct 19;20(1):774. (PMID: 33076856)
Cells. 2023 Jan 09;12(2):. (PMID: 36672197)
Clin Chem Lab Med. 2020 Jun 25;58(7):1131-1134. (PMID: 32119647)
Biochem Med (Zagreb). 2021 Oct 15;31(3):030501. (PMID: 34658642)
Thorax. 2021 Apr;76(4):405-407. (PMID: 33273028)
World J Hepatol. 2023 Jan 27;15(1):41-51. (PMID: 36744167)
Platelets. 2020 May 18;31(4):490-496. (PMID: 32297540)
J Rehabil Med. 2020 May 25;52(5):jrm00063. (PMID: 32449782)
APMIS. 2022 May;130(5):243-252. (PMID: 35114008)
Life Sci. 2020 Sep 15;257:118102. (PMID: 32687918)
Lancet. 2020 Feb 15;395(10223):497-506. (PMID: 31986264)
Hamostaseologie. 2021 Oct;41(5):379-385. (PMID: 34695854)
Biochem J. 2022 Feb 17;479(4):537-559. (PMID: 35195253)
Front Med (Lausanne). 2021 Aug 17;8:663670. (PMID: 34490284)
BMJ. 2020 Aug 11;370:m3026. (PMID: 32784198)
Lancet. 2021 Jan 16;397(10270):220-232. (PMID: 33428867)
Am J Hematol. 2020 Jul;95(7):834-847. (PMID: 32282949)
Nature. 2021 Jun;594(7862):259-264. (PMID: 33887749)
Eur Rev Med Pharmacol Sci. 2022 Jul;26(14):5268-5277. (PMID: 35916827)
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):145-146. (PMID: 33341598)
Clin Chim Acta. 2020 Oct;509:235-243. (PMID: 32533986)
Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028. (PMID: 32286245)
Cell Mol Immunol. 2020 May;17(5):533-535. (PMID: 32203188)
Clin Infect Dis. 2021 Dec 6;73(11):e4058-e4063. (PMID: 33252665)
Int J Lab Hematol. 2021 Apr;43(2):160-168. (PMID: 33264492)
Br J Haematol. 2020 Jul;190(2):179-184. (PMID: 32453877)
Nat Med. 2021 Apr;27(4):601-615. (PMID: 33753937)
Iran J Public Health. 2022 Jan;51(1):88-95. (PMID: 35223629)
فهرسة مساهمة: Keywords: blood cell count; erythrocyte indices; hematological tests; laboratory markers; long COVID
تواريخ الأحداث: Date Created: 20230428 Date Completed: 20230501 Latest Revision: 20230501
رمز التحديث: 20230501
مُعرف محوري في PubMed: PMC10142608
DOI: 10.3390/v15040879
PMID: 37112859
قاعدة البيانات: MEDLINE
الوصف
تدمد:1999-4915
DOI:10.3390/v15040879